Ariel Skelley/DigitalVision via Getty Images
Private equity firm Thoma Bravo is in advanced discussions to acquire patient record software provider NextGen Healthcare (NASDAQ:NXGN).
Thoma Bravo may announce a deal as soon as this week, according to a Bloomberg report on Monday, which cited people familiar with the situation.
The report comes after a Reuters report late last month that NextGen (NXGN) was exploring options, including a sale. NextGen has a market cap of $1.3 billion.
NextGen (NXGN) competitors include Athenahealth, Oracle (ORCL), EClincalWorks, Epic Systems, Greenway Health, Veradigm (MDRX), and Modernizing Medicine, according to the company’s latest 10-K filing.
NextGen’s (NXGN) short interest is 5.4%.
